Request an Edit
Skip to main content
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Utility Nav
CHOP.EDU
Careers
Ways to Give
Healthcare Professionals
International
Children's Hospital of Philadelphia
Menu
SEARCH
Main navigation
Find People
Our Research
Clinical Trials
About
Innovation
Faculty & Staff Resources
Make a Gift
Fibrodysplasia Ossificans Progressive
1 - 1 of
1
FDA Approval, Mitochondrial Dysfunction, Pediatric Headaches
Published on
Aug 18, 2023
in
Cornerstone Blog
The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.
